PurchasingPolicy.orgPURCHASINGPOLICYBETA
← Back to Influence Map
Entity DossierOrganization

GSK (FKA GLAXOSMITHKLINE INC.)

DC · US

pharmaceuticals

Tracked direct giving

$0

Tracked donations to candidate

$0

LDA reported lobbying spend

$8,060,000

Connections

5

Lobbying Activity Detail

Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.

Top Lobbying Issues

BUDBudget/Appropriations
$11.7M
CPTCopyright/Patent/Trademark
$11.7M
HCRHealth Issues
$11.7M
MMMMedicare/Medicaid
$11.7M
TRDTrade
$11.7M

Lobbying Firms Retained

GSK (FKA GLAXOSMITHKLINE INC.)$11.7M

Bills Referenced in Lobbying Filings

march-inH.R. 8333

Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.

Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome

Click a node to see details

Double-click to expand its connections

Relationships

TypeConnected ToDetailsSource
Lobbied forMARCH-IN Rights Proposal (NIH Framework)LDA filing: lobbied on NIH March-In Rights, period 1st Quarter (Jan 1 - Mar 31), reported amount $1,700,000Source
Lobbied forBIOSECURE Act (H.R.8333/S.3558)LDA filing: lobbied on BIOSECURE Act, period 2nd Quarter (Apr 1 - June 30), reported amount $1,510,000Source
Lobbied forUkraine Security Assistance SupplementalLDA filing: lobbied on Ukraine Security Supplemental, period 1st Quarter (Jan 1 - Mar 31), reported amount $1,700,000Source
Lobbied forSugar Reform Act (S.832, 118th Congress)LDA filing: lobbied on Sugar Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $800,000Source
Lobbied forRights to Federally Funded Inventions and Licensing of Government Owned InventionsLobbied on march-in — matched LDA filing topic to Federal Register rule.Source